Skip to main content

Advertisement

Table 2 Summary of data included in the analysis

From: New approaches to measuring anthelminthic drug efficacy: parasitological responses of childhood schistosome infections to treatment with praziquantel

Country Participants Mean age (SD) QD protocola PZQ regimen Follow-up days Ref.
Schistosoma haematobium
Côte d’Ivoire 6 5 (0) 1 UF × 1 urine sample 1 × 40 mg/kg 21 [20]
Côte d’Ivoire 86 11.1 (1.9) 1 UF × 2 urine samples 1 × 40 mg/kg 21 [21]
Kenya 79 11.3 (3.1) 1 UF × 4 urine samples 1 × 40 mg/kg 42 [19]
Schistosoma mansoni
Côte d’Ivoire 35 3.8 (1.2) 2 KK × 2 stool samples 1 × 40 mg/kg 21 [20]
Uganda 503 4.2 (1.8) 2 KK × 2 stool samples 1 × 40 mg/kg 21 [26]
Côte d’Ivoire 58 11.2 (4.1) 1 KK × 3 stool samples 1 × 40 mg/kg 42 [24]
Côte d’Ivoire 49 8.9 (2.4) 2 KK × 2 stool samples 1 × 40 mg/kg 21 [25]
Côte d’Ivoire 85 10.0 (1.42) 1 KK x 4 stool samples 1 × 40 mg/kg 28 [23]
Côte d’Ivoire 261 9.6 (2.1) 1 KK x 5 stool samples 1 × 60 mg/kgb 28 [22]
  1. Abbreviations: KK Kato-Katz, PZQ praziquantel, QD quantitative diagnostic, SD standard deviation, UF urine filtration
  2. aMultiple samples of urine or stool were taken on consecutive days; b 2 × 30 mg/kg given 3 hours apart